SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028548
Filing Date
2018-11-08
Accepted
2018-11-08 16:10:18
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20180930.htm 10-Q 2847693
2 EX-31.1 fgen-ex311_9.htm EX-31.1 8315
3 EX-31.2 fgen-ex312_10.htm EX-31.2 8355
4 EX-32.1 fgen-ex321_7.htm EX-32.1 7880
  Complete submission text file 0001564590-18-028548.txt   8893586

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fgen-20180930.xml EX-101.INS 2177828
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20180930.xsd EX-101.SCH 41771
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20180930_cal.xml EX-101.CAL 49448
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20180930_def.xml EX-101.DEF 177925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20180930_lab.xml EX-101.LAB 319028
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20180930_pre.xml EX-101.PRE 290977
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 181169761
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1